EPIRUBICIN - A REVIEW OF THE PHARMACOLOGY, CLINICAL ACTIVITY, AND ADVERSE-EFFECTS OF AN ADRIAMYCIN ANALOG

被引：230

作者：

CERSOSIMO, RJ

HONG, WK

机构：

[1] VET ADM MED CTR JAMAICA PLAIN,BOSTON,MA 02130

[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,HEAD & NECK MED ONCOL SECT,HOUSTON,TX 77030

来源：

关键词：

D O I：

10.1200/JCO.1986.4.3.425

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：425 / 439

页数：15

共 103 条

[1]

ABOUD A, 1983, P AM SOC CLIN ONCOL, V2, P107

[2]

BENEDETTO P, 1982, P AM ASS CLIN ONCOL, V1, P114

[3]

BERETTA G, 1983, 2ND EUR C CLIN ONC

[4]

BERMAN E, 1984, CANCER TREAT REP, V68, P679

[5]

BITRAN JD, 1979, CANCER TREAT REP, V63, P2049

[6]

BODEY GP, 1983, 13TH P INT C CHEM, V215, P23

[7]

BONADONNA G, 1981, ANTHRACYCLINE ANTIBI, P455

[8]

BONADONNA G, 1984, ADV ANTHRACYCLINE CH, P63

[9] TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN [J].

BONFANTE, V ;

VILLANI, F ;

BONADONNA, G .

TUMORI JOURNAL, 1982, 68 (02) :105-111

[10]

BONFANTE V, 1979, CANCER TREAT REP, V63, P915